Tag: Cancer: Lymphoma
Frailty Mars Outcomes After aHSCT in Lymphoid Malignancies
Links found for frailty with in-hospital mortality, prolonged length of stay for patients with NHL, HL, MM undergoing aHSCT
Nomogram May Help Predict Survival in Primary Intestinal NHL
Prediction accuracy of the nomogram higher than that of Ann Arbor Stage for primary intestinal non-Hodgkin lymphoma patients
ASH: Axicabtagene Ciloleucel Slows Large B-Cell Lymphoma
Event-free survival prolonged with axi-cel versus standard care as second-line therapy for refractory, relapsed disease
Stem Cell Transplant Reviewed for Peripheral T-Cell Lymphoma
Three- and five-year overall survival similar with allogeneic or autologous HSCT, but transplant-related mortality higher with allogeneic HSCT
Novel Index IDs Prognosis in Adults With Burkitt Lymphoma
Validated international prognostic index stratifies patients according to low, intermediate, high risk
Breyanzi Approved for Certain Types of Large B-Cell Lymphoma
The CAR T cell therapy OK'd for patients who have not responded to or have relapsed after receiving two or more other systemic treatments
ASH: CAR T-Cell Therapy Promising for Relapsed/Refractory iNHL
Phase 2 study reveals high objective response rate for CAR T-cell therapy in patients with follicular lymphoma, marginal zone lymphoma
Rates of VTE, Major Bleeding High in Primary CNS Lymphoma
Pulmonary embolism and major bleeding linked to increased mortality risk
